phase readout
saveNCT05918042: A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
COMPLETEDupdated 48m ago
community read0 votes
Sponsor: AstraZeneca. Phase: . Conditions: Ovarian Cancer
view source ↗
comments(0)
5-min edit window · permanent after that